Research Article
Efficacy of Perampanel in Nocturnal Seizures in Adult Patients with Epilepsy
Table 1
Demographic and clinical baseline characteristics.
| | Variable | |
| | Age, years ( (range)) | (16-77) | | Sex (male), (%) | 29 (60.4) | | Age at epilepsy onset, years ( (range)) | (0-77) | | Epilepsy duration, years ( (range)) | (0.5-63) | | Epilepsy type, (%) | | | Focal | 39 (81.3) | | Generalized | 6 (12.5) | | Focal/generalized | 1 (2.1) | | Unknown | 2 (4.2) | | Focal localization (), (%) | | | Frontal | 12 (30.8) | | Occipital | 1 (2.6) | | Temporal | 25 (64.1) | | Undetermined | 1 (2.6) | | Syndrome, (%) | | | Focal epilepsy of unknown etiology | 14 (29.2) | | Focal epilepsy of structural etiology | 29 (60.4) | | Idiopathic generalized epilepsy | 3 (6.3) | | Juvenile myoclonic epilepsy | 1 (2.1) | | Other | 1 (2.1) | | Etiology, (%) | | | Unknown | 14 (29.2) | | Structural | 27 (56.3) | | Infectious | 2 (4.2) | | Genetics | 5 (10.4) | | Specific cause (), (%) | | | Vascular | 3 (11.1) | | Tumor | 5 (18.5) | | Mesial sclerosis | 8 (29.6) | | Malformation cortical development | 8 (29.6) | | Cavernoma/arteriovenous malformation | 1 (3.7) | | Postanoxic encephalopathy after cardiac arrest | 1 (3.7) | | Neonatal anoxia | 1 (3.7) | | Drug-resistant epilepsy, (%) | 37 (70.8) |
|
|
CNS: central nervous system; SD: standard deviation.
|
